| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | vesicle docking | 2.92e-05 | 65 | 56 | 4 | GO:0048278 | |
| GeneOntologyCellularComponent | replication fork | 5.80e-05 | 77 | 57 | 4 | GO:0005657 | |
| GeneOntologyCellularComponent | Golgi transport complex | 3.24e-04 | 10 | 57 | 2 | GO:0017119 | |
| HumanPheno | Functional abnormality of the bladder | 2.52e-05 | 590 | 20 | 10 | HP:0000009 | |
| HumanPheno | Abnormality of the bladder | 3.97e-05 | 621 | 20 | 10 | HP:0000014 | |
| Domain | - | 1.27e-04 | 6 | 55 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.27e-04 | 6 | 55 | 2 | PS51460 | |
| Domain | - | 1.27e-04 | 6 | 55 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.27e-04 | 6 | 55 | 2 | IPR003108 | |
| Domain | GAS2 | 1.27e-04 | 6 | 55 | 2 | PF02187 | |
| Domain | GAS2 | 1.27e-04 | 6 | 55 | 2 | SM00243 | |
| Domain | Plectin_repeat | 1.77e-04 | 7 | 55 | 2 | IPR001101 | |
| Domain | zf-MIZ | 1.77e-04 | 7 | 55 | 2 | PF02891 | |
| Domain | Plectin | 1.77e-04 | 7 | 55 | 2 | PF00681 | |
| Domain | ZF_SP_RING | 1.77e-04 | 7 | 55 | 2 | PS51044 | |
| Domain | PLEC | 1.77e-04 | 7 | 55 | 2 | SM00250 | |
| Domain | Znf_MIZ | 2.36e-04 | 8 | 55 | 2 | IPR004181 | |
| Domain | - | 3.32e-04 | 449 | 55 | 7 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.79e-04 | 459 | 55 | 7 | IPR013083 | |
| Domain | ZF_BBOX | 1.69e-03 | 80 | 55 | 3 | PS50119 | |
| Domain | Znf_B-box | 1.75e-03 | 81 | 55 | 3 | IPR000315 | |
| Domain | Actinin_actin-bd_CS | 2.07e-03 | 23 | 55 | 2 | IPR001589 | |
| Domain | Spectrin | 2.07e-03 | 23 | 55 | 2 | PF00435 | |
| Domain | ACTININ_2 | 2.07e-03 | 23 | 55 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.07e-03 | 23 | 55 | 2 | PS00019 | |
| Domain | SPRY | 2.15e-03 | 87 | 55 | 3 | SM00449 | |
| Domain | SPRY | 2.68e-03 | 94 | 55 | 3 | PF00622 | |
| Domain | SPRY_dom | 2.68e-03 | 94 | 55 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 2.76e-03 | 95 | 55 | 3 | IPR001870 | |
| Domain | B302_SPRY | 2.76e-03 | 95 | 55 | 3 | PS50188 | |
| Domain | Spectrin_repeat | 3.29e-03 | 29 | 55 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.99e-03 | 32 | 55 | 2 | IPR018159 | |
| Domain | SPEC | 3.99e-03 | 32 | 55 | 2 | SM00150 | |
| Domain | zf-C3HC4 | 4.19e-03 | 223 | 55 | 4 | PF00097 | |
| Pubmed | RPL10A RAD18 DST TRIM9 ZMIZ2 EIF4G1 MECOM CEP152 ZMIZ1 ZNF850 ZBTB1 ZEB2 FILIP1L | 5.06e-07 | 1429 | 58 | 13 | 35140242 | |
| Pubmed | 2.64e-06 | 130 | 58 | 5 | 12421765 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18053775 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11002341 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 36443618 | ||
| Pubmed | UNC13B DST PDE7A TRIM9 EIF4G1 ADNP2 MACF1 USP16 ZEB2 RBCK1 SPRYD7 | 7.75e-06 | 1285 | 58 | 11 | 35914814 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 8.19e-06 | 3 | 58 | 2 | 12399109 | |
| Pubmed | The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. | 8.19e-06 | 3 | 58 | 2 | 17584785 | |
| Pubmed | 1.43e-05 | 1116 | 58 | 10 | 31753913 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18490513 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8954775 | ||
| Pubmed | 2.72e-05 | 103 | 58 | 4 | 10574462 | ||
| Pubmed | Sexually dimorphic gene expression of the Zimp7 and Zimp10 genes in embryonic gonads. | 2.72e-05 | 5 | 58 | 2 | 19931425 | |
| Pubmed | The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. | 2.72e-05 | 5 | 58 | 2 | 16777850 | |
| Pubmed | 2.91e-05 | 963 | 58 | 9 | 28671696 | ||
| Pubmed | 2.94e-05 | 105 | 58 | 4 | 22493164 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 3.09e-05 | 742 | 58 | 8 | 26871637 | |
| Pubmed | 3.76e-05 | 225 | 58 | 5 | 12168954 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 20159969 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.95e-05 | 120 | 58 | 4 | 31413325 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.30e-05 | 398 | 58 | 6 | 35016035 | |
| Pubmed | 5.60e-05 | 402 | 58 | 6 | 24722188 | ||
| Pubmed | 6.94e-05 | 418 | 58 | 6 | 34709266 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 11929878 | ||
| Pubmed | The binary interacting network of the conserved oligomeric Golgi tethering complex. | 7.60e-05 | 8 | 58 | 2 | 15047703 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 11980916 | ||
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 27066481 | ||
| Pubmed | 1.21e-04 | 151 | 58 | 4 | 17043677 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 28361920 | ||
| Pubmed | 1.41e-04 | 60 | 58 | 3 | 20682791 | ||
| Pubmed | DNA damage-induced ubiquitylation of RFC2 subunit of replication factor C complex. | 1.49e-04 | 11 | 58 | 2 | 18245774 | |
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 1.49e-04 | 11 | 58 | 2 | 16815997 | |
| Pubmed | 1.49e-04 | 481 | 58 | 6 | 28190767 | ||
| Pubmed | 1.73e-04 | 709 | 58 | 7 | 22988430 | ||
| Pubmed | Selection system for genes encoding nuclear-targeted proteins. | 2.46e-04 | 14 | 58 | 2 | 9853615 | |
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 19762545 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.86e-04 | 1024 | 58 | 8 | 24711643 | |
| Pubmed | 2.97e-04 | 191 | 58 | 4 | 33762435 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.80e-04 | 1353 | 58 | 9 | 29467282 | |
| Pubmed | A physical interaction network of dengue virus and human proteins. | 4.11e-04 | 18 | 58 | 2 | 21911577 | |
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 2542606 | ||
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 21689717 | ||
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 19668339 | ||
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 7479878 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 5.46e-04 | 95 | 58 | 3 | 29643511 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.58e-04 | 861 | 58 | 7 | 36931259 | |
| Pubmed | SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination. | 5.62e-04 | 21 | 58 | 2 | 24958773 | |
| Pubmed | 5.90e-04 | 407 | 58 | 5 | 12693553 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 6.41e-04 | 1455 | 58 | 9 | 22863883 | |
| Pubmed | 6.76e-04 | 23 | 58 | 2 | 23725790 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.56e-04 | 1489 | 58 | 9 | 28611215 | |
| Pubmed | 8.37e-04 | 110 | 58 | 3 | 27889896 | ||
| Pubmed | 9.34e-04 | 27 | 58 | 2 | 18685082 | ||
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 1.00e-03 | 28 | 58 | 2 | 26812015 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.10e-03 | 1257 | 58 | 8 | 36526897 | |
| Pubmed | 1.30e-03 | 486 | 58 | 5 | 20936779 | ||
| Pubmed | Genome-wide association scan of dental caries in the permanent dentition. | 1.40e-03 | 33 | 58 | 2 | 23259602 | |
| Pubmed | 1.55e-03 | 1327 | 58 | 8 | 32694731 | ||
| GeneFamily | Zinc fingers MIZ-type | 9.95e-05 | 7 | 40 | 2 | 85 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.33e-04 | 8 | 40 | 2 | 939 | |
| GeneFamily | Components of oligomeric golgi complex | 1.33e-04 | 8 | 40 | 2 | 493 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.92e-04 | 15 | 40 | 2 | 529 | |
| GeneFamily | Ring finger proteins | 3.11e-03 | 275 | 40 | 4 | 58 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.66e-03 | 718 | 40 | 6 | 28 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_UP | 5.18e-06 | 199 | 58 | 6 | M6289 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.65e-05 | 856 | 58 | 10 | M4500 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RPL10A CREBRF GPR155 VPS11 NIBAN1 PDE7A WWC3 MACF1 CPA3 IKZF1 ZBTB1 ZEB2 ARAP2 | 1.78e-05 | 1492 | 58 | 13 | M40023 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.16e-05 | 81 | 58 | 4 | M39253 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | TRIM16 GPR155 NIBAN1 ADAMTS3 TRIM9 P3H2 MECOM CPA3 IKZF1 ZMIZ1 NDRG4 FILIP1L | 7.89e-06 | 967 | 57 | 12 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | TRIM16 GPR155 NIBAN1 ADAMTS3 TRIM9 MECOM CPA3 IKZF1 ZMIZ1 NDRG4 FILIP1L | 4.44e-05 | 967 | 57 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.27e-05 | 384 | 57 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.51e-05 | 276 | 57 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 9.80e-05 | 172 | 57 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.21e-04 | 417 | 57 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | 1.45e-04 | 429 | 57 | 7 | gudmap_kidney_adult_Mesangium_Meis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | TRIM16 GPR155 NIBAN1 RABL2A ADAMTS3 MECOM CPA3 IKZF1 ZMIZ1 FILIP1L | 2.27e-04 | 968 | 57 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 2.43e-04 | 209 | 57 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 2.69e-04 | 804 | 57 | 9 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 2.90e-04 | 639 | 57 | 8 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 2.98e-04 | 815 | 57 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | 3.34e-04 | 492 | 57 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.00e-07 | 128 | 58 | 5 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.00e-07 | 128 | 58 | 5 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 172 | 58 | 5 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 172 | 58 | 5 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 184 | 58 | 5 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.39e-06 | 186 | 58 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.87e-06 | 190 | 58 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | MatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4) | 5.12e-06 | 192 | 58 | 5 | 630444302511f511ec6976bc045a3b4b9d8d4547 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 195 | 58 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.66e-06 | 196 | 58 | 5 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.95e-06 | 198 | 58 | 5 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.10e-06 | 199 | 58 | 5 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-06 | 200 | 58 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.25e-06 | 200 | 58 | 5 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.90e-05 | 135 | 58 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-7|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.64e-05 | 167 | 58 | 4 | 01c42e555913b17e62846325cc17b3d8f92da1e1 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-05 | 170 | 58 | 4 | 1f994b690e881106a5d54b3080ccce6260bc3ac5 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 173 | 58 | 4 | 9eaec30f9a3655b53ece1b66848201a7f85bbdf5 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 7.79e-05 | 174 | 58 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.96e-05 | 175 | 58 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-05 | 176 | 58 | 4 | 581d78811b2d99f38a2c7cc268aeb1cf932379c2 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 8.14e-05 | 176 | 58 | 4 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 176 | 58 | 4 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.32e-05 | 177 | 58 | 4 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-05 | 178 | 58 | 4 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-05 | 178 | 58 | 4 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.69e-05 | 179 | 58 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.69e-05 | 179 | 58 | 4 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.88e-05 | 180 | 58 | 4 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 9.47e-05 | 183 | 58 | 4 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.47e-05 | 183 | 58 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 183 | 58 | 4 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 183 | 58 | 4 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.67e-05 | 184 | 58 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.67e-05 | 184 | 58 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.67e-05 | 184 | 58 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.87e-05 | 185 | 58 | 4 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.87e-05 | 185 | 58 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.87e-05 | 185 | 58 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 186 | 58 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 186 | 58 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 187 | 58 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 187 | 58 | 4 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.05e-04 | 188 | 58 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 188 | 58 | 4 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.05e-04 | 188 | 58 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.07e-04 | 189 | 58 | 4 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 189 | 58 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-04 | 189 | 58 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 190 | 58 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 190 | 58 | 4 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 58 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 58 | 4 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.12e-04 | 191 | 58 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 191 | 58 | 4 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 191 | 58 | 4 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.12e-04 | 191 | 58 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 191 | 58 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 191 | 58 | 4 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.12e-04 | 191 | 58 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.12e-04 | 191 | 58 | 4 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.14e-04 | 192 | 58 | 4 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 192 | 58 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.14e-04 | 192 | 58 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-04 | 192 | 58 | 4 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-04 | 192 | 58 | 4 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.16e-04 | 193 | 58 | 4 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 193 | 58 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | remission|World / disease stage, cell group and cell class | 1.16e-04 | 193 | 58 | 4 | 86cfd0c230ba96a43d343216935952fff6a5254e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | COVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.16e-04 | 193 | 58 | 4 | 780e23e2705fc5c1b70e37568b79731ced5038bd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 193 | 58 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.19e-04 | 194 | 58 | 4 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-04 | 194 | 58 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 194 | 58 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 194 | 58 | 4 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | CV-Moderate-0|CV / Virus stimulation, Condition and Cluster | 1.19e-04 | 194 | 58 | 4 | 9ff69139dae007fcc349daefcb5021defb0e0d2a | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 195 | 58 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 1.21e-04 | 195 | 58 | 4 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 195 | 58 | 4 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 1.23e-04 | 196 | 58 | 4 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 196 | 58 | 4 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 196 | 58 | 4 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 196 | 58 | 4 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.23e-04 | 196 | 58 | 4 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 196 | 58 | 4 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.26e-04 | 197 | 58 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 197 | 58 | 4 | d14e1f2ba94240c61eac435db43508a224d606a8 | |
| ToppCell | CV-Severe-0|Severe / Virus stimulation, Condition and Cluster | 1.26e-04 | 197 | 58 | 4 | d13fc20b31ab6d9117437fba319c72f3a552858f | |
| Disease | coronary artery disease | VPS11 ADAMTS3 SEPTIN5 ZBED6 MECOM MAP3K7CL COG5 SLC2A12 ZEB2 | 4.41e-04 | 1194 | 57 | 9 | EFO_0001645 |
| Disease | Malignant neoplasm of breast | 1.02e-03 | 1074 | 57 | 8 | C0006142 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.18e-03 | 239 | 57 | 4 | EFO_0010934 | |
| Disease | Colorectal Carcinoma | 2.30e-03 | 702 | 57 | 6 | C0009402 | |
| Disease | platelet component distribution width | 3.30e-03 | 755 | 57 | 6 | EFO_0007984 | |
| Disease | selective IgA deficiency disease | 3.59e-03 | 46 | 57 | 2 | EFO_1001929 | |
| Disease | dyslexia | 3.83e-03 | 162 | 57 | 3 | EFO_0005424 | |
| Disease | anthropometric measurement | 4.23e-03 | 168 | 57 | 3 | EFO_0004302 | |
| Disease | sitting height ratio | 4.40e-03 | 51 | 57 | 2 | EFO_0007118 | |
| Disease | Diffuse Large B-Cell Lymphoma | 5.10e-03 | 55 | 57 | 2 | C0079744 | |
| Disease | hippocampal atrophy | 5.28e-03 | 56 | 57 | 2 | EFO_0005039 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VDRCERTYQQHHEAM | 671 | O94986 | |
| HNEKVNFHVECKDYV | 221 | Q8IUR6 | |
| HLYRVQKCSEINHMN | 1246 | Q8WZ64 | |
| HEDTYHMQQCLQERV | 466 | Q96M86 | |
| NVYQVHMEVAHKHSE | 706 | Q6IQ32 | |
| KRHQEFVHMYNAQCD | 276 | Q9NS91 | |
| QYHTHQENGIEICMD | 231 | Q7Z3E1 | |
| KNNICFMSHHQEELV | 571 | Q8TD20 | |
| HMLSHTEEREYKCDQ | 281 | Q03112 | |
| YHKAHACIMVFDIQR | 91 | Q9UBK7 | |
| AACEVAQQEMEYDHK | 306 | Q9Y697 | |
| EIKMTCQQFIHYHRD | 746 | Q7Z3F1 | |
| LQQCLQHTEKMHEYL | 3391 | Q03001 | |
| HEQMNCKEYQEDLAL | 406 | Q9BYM8 | |
| AAKHCIMQANAEYHQ | 246 | Q8WUM4 | |
| HAADVTQAMHCYLKE | 216 | Q13946 | |
| QCLDYHHQEMQALKE | 356 | Q6ZTU2 | |
| LEEHKERCHNYLESM | 216 | Q13422 | |
| EAIADHYMQVLVCQH | 271 | Q8IVL5 | |
| VCEIHFHEINNKMVE | 166 | O43347 | |
| CHQIMKNLQAHYEDF | 986 | Q9UPN3 | |
| KLMDHIYAVCGQVQH | 336 | Q9UP83 | |
| DVAYMKQLVHDGTHC | 656 | O15072 | |
| ALDQNKMHYEILIHD | 81 | P15088 | |
| IHEYMATEDLICHLQ | 726 | Q4L180 | |
| AFMVHVCQDEHQLYN | 371 | Q96JB2 | |
| ADQHHQEYKVMLEVC | 1546 | Q8IZJ3 | |
| HDTNIYCRMDHKAEV | 236 | P40198 | |
| EEYLHLNDMKEAVQC | 1251 | Q04637 | |
| IQNVHSAKDYLHCME | 341 | Q6UXX5 | |
| HYKIGALCMNIIDHE | 216 | Q92845 | |
| MEVFKQHCQIAEEYH | 56 | P57077 | |
| QHCQIAEEYHEVKKE | 61 | P57077 | |
| KAHHECTDQKVYQAV | 221 | Q6NW40 | |
| IFHAVVQYCKMHEEQ | 1671 | Q2M3C7 | |
| CTEKNEDRHALHMDY | 2536 | Q8WUY3 | |
| HMHDLKDVTCDVHYE | 291 | Q99719 | |
| DVHYENYRAHCIQQM | 301 | Q99719 | |
| KMEAYNIDETCGRHH | 206 | Q8WW24 | |
| MQEITKHFVVCHVDA | 56 | Q9ULP0 | |
| KVYNENLVHMIEHAQ | 136 | O75934 | |
| HVELNVYLNGKNMHC | 136 | Q5W111 | |
| HMQHEQYRQVISVCE | 696 | Q9H270 | |
| NHISQEGVMHKEYCV | 496 | Q9Y5T5 | |
| HTNMIHVENVYEEIL | 531 | Q9BZQ8 | |
| EHEKDHLCKSADYMN | 1021 | O14795 | |
| MIQHCVNANIDEAYK | 266 | P35250 | |
| QQHCDEAKAVDIPHM | 71 | P62906 | |
| ELQFKCYHHEDRQMN | 466 | Q8NF64 | |
| DHELENHSMYCVQCK | 231 | Q9C026 | |
| EQAHNLTIEMKNHYV | 731 | Q9BZF9 | |
| QLEQHMDVHLYTCGI | 676 | Q9Y2K1 | |
| HCLNMVIQDFFCEHK | 586 | P86452 | |
| CMVNYCEEHLQPHQV | 96 | O95361 | |
| NNIVHAEEKHYKCQE | 281 | Q9NSJ1 | |
| LHQHERYLCKMNEEI | 596 | O60315 | |
| ELAQEEYQQLHKMCE | 51 | Q9ULE0 | |
| IQHQKMYTDERPHEC | 241 | A8MQ14 | |
| LELQFKCYHHEDRQM | 606 | Q9ULJ6 | |
| VCMHLTNYAINKHNE | 286 | A6NNM8 |